Search for: "Apotex"
Results 361 - 380
of 1,051
Sort by Relevance
|
Sort by Date
13 Apr 2014, 8:59 am
Apotex Inc. v. [read post]
12 Apr 2014, 6:39 am
Apotex, Inc., 480 F.3d 1348, 1364 (Fed. [read post]
11 Apr 2014, 11:29 am
Apotex Inc., No. 2013-1128, -1161, -1162, -1163, -1164 (April 11, 2014).IssueThe issue in this case is whether it would have been obvious at the time of invention to select a once monthly oral dosing regimen of ibandronate to treat osteoporosis and to set that dose at 150 mg [based on prior art references teaching a daily dosage amount].Hoffmann-La Roche, Inc. at *9 (text added).Holding[T]he prior art pointed to a monthly treatment of 150 mg of ibandronate. [read post]
10 Apr 2014, 5:17 pm
Apotex Corp., 439 F.3d 1312, 1320 (Fed. [read post]
8 Apr 2014, 9:55 am
Apotex, Inc., 480 F.3d1348, 1364 (Fed. [read post]
7 Apr 2014, 9:59 pm
The case involved patentee Senju Pharmaceutical's (joined by Kyorin Pharmaceutical Co. and Allergan, Inc.) suit against Apotex in response to a Paragraph IV certification against Senju's patented ocular antimicrobial agent containing the drug Gatifloxacin as claimed in U.S. [read post]
3 Apr 2014, 9:55 pm
• Defendants: Apotex Inc.; Apotex Corp. [read post]
1 Apr 2014, 7:17 pm
Apotex Inc., No. 2013-1027 (Fed. [read post]
1 Apr 2014, 6:11 am
Apotex The outcome was that Senju's claims were barred by claim preclusion. [read post]
20 Mar 2014, 4:15 am
Alcon has not initiated litigation against Apotex but did initiate litigation against Mylan and Micro Labs after Apotex filed its IPRs. [read post]
19 Mar 2014, 9:00 am
Apotex relies on hundreds of prior art documents. [read post]
5 Mar 2014, 10:05 am
By Martin Miller The U.S. [read post]
10 Feb 2014, 2:01 am
Apotex involving the Pfizer’s patenting of the besylate form of amlodipine (salt form) which Apotex claimed was obvious in the light of Pfizer’s own patent on the base compound amlodipine.16 The CAFC, in agreeing with Apotex that the patent on the besylate form was invalid, highlighted the besylate form lacked the unexpected superior results from the base compound in order for the salt form to be patented.17 Indeed, the Manual for Patent Examination Procedure… [read post]
29 Jan 2014, 9:12 pm
Apotex, Inc., 480 F.3d 1348, 1372 (Fed. [read post]
14 Jan 2014, 9:30 am
Apotex Inc., 2013 FC 1265 (CanLII) (December 18, 2013) [60] Roche has claimed $1,288.86 for Quicklaw and Westlaw fees. [read post]
13 Jan 2014, 9:59 pm
By Gary Cox, Craig Humphris and Donna Meredith -- In the decision of Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50 (order), the High Court of Australia, Australia's supreme court, confirmed that methods of medical treatment are a "manner of manufacture" and therefore represent a patentable invention in Australia. [read post]
8 Jan 2014, 3:00 am
Apotex, Inc., 655 F.3d 1352, 1360 (Fed. [read post]
5 Jan 2014, 5:06 am
The patent is owned by French pharmaceutical company Les Laboratoires Servier, and was challenged by generic drug manufacturer Apotex, which wishes to bring its own version of the drug to market.Not surprisingly, Apotex applied to the court for revocation of the Servier patent on a number of additional grounds: lack of novelty; lack of inventive step; lack of fair basis for the claims in the description; and that the patent was obtained by false suggestion or… [read post]
3 Jan 2014, 7:49 am
Apotex Corporation, the largest generic drug manufacturer in Canada, was the remaining defendant. [read post]
24 Dec 2013, 5:45 am
In the last decade, the Supreme Court of Canada has canvassed many important issues in copyright law including the scope of the rights of reproduction and authorization, what makes a work original, and how to apply the fair dealing defense. [read post]
